•  
  •  
  •  
  •  

2025-11-25 14:09:47

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Shri Amresh Prasad appointed as Executive Director of Union Bank of India
  • Transformers and Rectifiers India Ltd receives order worth Rs. 389.97 crores
  • South West Pinnacle Exploration Ltd awarded LOA by NALCO
  • B L Kashyap and Sons Ltd receives new order from DLF Home Developers Ltd
  • IKS Health Expands Presence with the Launch of Its New Office in Coimbatore

Keywords Selected:  Type2Diabetes

Stock Report

  • Glenmark Pharma is first to launch a Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 Diabetes in Adults with Co-morbidities
  • Cipla signs perpetual licensing agreement with Novartis Pharma AG for Galvus® range for diabetes therapy in India
  • Torrent Pharmaceuticals Ltd enters into co-marketing partnership with Boehringer Ingelheim India Pvt Ltd
  • Glenmark launches Teneligliptin + Dapagliflozin Fixed Dose Combination, for Adults with Type 2 Diabetes, having Comorbidities
  • Glenmark becomes the First to launch Lobeglitazone in India for Uncontrolled Type 2 Diabetes in Adults
  • Zydus has launched Sitaglyn® and Siglyn®, for the management of Type 2 diabetes
  • Glenmark launches Sitagliptin and its Fixed Dose Combinations
  • Glenmark to launch Drug for Type 2 Diabetes in India

Latest Post

  • Shri Amresh Prasad appointed as Executive Director of Union Bank of India
  • Transformers and Rectifiers India Ltd receives order worth Rs. 389.97 crores
  • South West Pinnacle Exploration Ltd awarded LOA by NALCO
  • B L Kashyap and Sons Ltd receives new order from DLF Home Developers Ltd
  • IKS Health Expands Presence with the Launch of Its New Office in Coimbatore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024